-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster III

Symposia: Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders Program: Oral and Poster Abstracts
Type: Poster
Monday, December 9, 2024: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Kitsada Wudhikarn, MD1, Evandro Bezerra, MD2, Yang Yang, MD3, Miguel-Angel Perales, MD4, Nitin Jain, MD5, Usama Gergis, MD, MBA3, Ahmed Aribi, MD6*, LaQuisa Hill, MD7*, Jessica T. Leonard, MD8, Forat Lutfi, MD9, Soyoung Kim, PhD10*, Matthew Bye, MPH10*, Zhen-Huan Hu, MPH11*, Hai-Lin Wang, MPH12*, Zhong-Cheng Luo, PhD12*, Rubina Siddiqi, PhD12*, Rita Damico Khalid, DO12*, Jessica Speiser, MPH12*, Marcelo C. Pasquini, MD, MS10, Partow Kebriaei, MD5 and Lori Muffly, MD13

1Chulalongkorn University, Bangkok, Thailand
2The Ohio State University, Columbus, OH
3Thomas Jefferson University, Philadelphia, PA
4Memorial Sloan Kettering Cancer Center, New York, NY
5The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA
7Baylor College of Medicine, Houston, TX
8Oregon Health & Science University, Portland, OR
9University of Kansas Health System, Kansas City, KS
10Center for International Blood and Marrow Transplant Research, Milwaukee, WI
11Kite Pharma, a Gilead Company, Santa Monica, CA
12Kite, a Gilead Company, Santa Monica, CA
13Stanford University, Stanford, CA

Samantha A. Hershenfeld, MD, BSc1*, Daniel McCormack, MSc2*, Ning Liu, PhD2* and Matthew C. Cheung, MD, MSc1,2

1Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
2ICES, Toronto, ON, Canada

Kimberly Ann Davidow, MD1, Thomas Z Rohan, BS2*, Cooper R Roslund2*, Pierluigi Porcu3, Alan S Khoo, MBBS4*, Christopher McNair, PhD5*, AnneMarie C Brescia, MD6* and Jonathan Powell, MD7*

1Lisa Dean Mosely Foundation Institute for Cancer and Blood Disorders, Nemours Children's Health - Delaware, Philadelphia, PA
2Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA
3Department of Medical Oncology, Sidney Kimmel Comprehensive Cancer Center, Thomas Jefferson University, Philadelphia, PA
4Sidney Kimmel Cancer Center,, Thomas Jefferson University, Philadelphia, PA
5Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
6Nemours Children's Health - Delaware, Wilmington, DE
7Lisa Dean Mosely Foundation Institute for Cancer and Blood Disorders, Nemour's Children's Health - Delaware, Wilmington, DE

Jean-Nicolas Champagne, MD1, Steven Huang, BSc2*, Rayan Ramadan3*, Christopher P. Venner, MD4, Khaled Ramadan, FRCPath5*, Laurie H. H. Sehn, MD4, Kerry J. Savage, MD, MSc6, Diego Villa, MD7, David W. Scott, MBChB, PhD8, Waleed Alduaij, PhD, MBChB9, Cynthia L. Toze, MD, MSc, FRCPC10 and Alina S. Gerrie, MD, MPH4

1BC Cancer Vancouver, Vancouver, BC, Canada
2Vancouver General Hospital, Vancouver, BC, CAN
3Providence Health Care Research Institute, Vancouver, BC, Canada
4Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
5St. Paul's Hospital Providence Health Care, Vancouver, BC, CAN
6Division of Medical Oncology, University of British Columbia, Vancouver, BC, Canada
7Centre for Lymphoid Cancer, BC Cancer – Vancouver Cancer Centre, Vancouver, BC, Canada
8Centre for Lymphoid Cancer, British Columbia Cancer, Vancouver, BC, Canada
9British Columbia Cancer Research Insitute, Vancouver, BC, Canada
10Leukemia/Bone Marrow Transplant Program of British Columbia, British Columbia Cancer Agency, Vancouver, Canada

William Schwartzman, MD1, Ang Gao, MS2*, Chul Ahn, PhD2*, Heather R Wolfe, MD3,4*, Praveen Ramakrishnan Geethakumari, MD, MS4, Farrukh T. Awan, MD5 and Elif Yilmaz, MD6

1Harold C. Simmons Comprehensive Cancer Center, UT Southwestern, Irving, TX
2Peter O’Donnell Jr. School of Public Health, UT Southwestern Medical Center, Dallas, TX
3University of Texas Southwestern Medical Center, Dallas, TX
4Section of Hematological Malignancies and Cellular Therapy, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX
5Southwestern Medical Center, Harold C. Simmons Comprehensive Cancer Center, The University of Texas, Dallas, TX
6Hematologic Malignancies and Cellular Therapy, University of Texas Southwestern Medical Center, Dallas, TX

Tycel J. Phillips, MD1, Alexey V. Danilov, MD, PhD2, Jia Ruan3, Krish Patel, MD4*, Anita Kumar, MD5, Yucai Wang, MD, PhD6, Gregory A. Maglinte7*, Erlene Seymour7* and Manali Kamdar, MD, MBBS8*

1City of Hope, Duarte, CA
2City of Hope National Medical Center, Duarte, CA
3Weill Cornell Medicine, New York, NY
4Swedish, Seattle, WA
5Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Mayo Clinic, Rochester, MN
7BeiGene, San Mateo, CA
8University of Colorado, Boulder, CO

Mrinal Joshirao, MD1, Lilibeth Torno, MD2,3*, Carol Hwang Lin, MD2, Arun Ranjan Panigrahi, MD4, Robert Raphael, MD5*, Griselda Alvarez, MD, HS6,7*, Robert Goldsby, MD8* and Dennis John Kuo, MD, MS9*

1Rady Children's Hospital, University of California San Diego, San Diego, CA
2Division of Oncology, Hyundai Cancer Institute, Children's Hospital of Orange County, Orange, CA
3University of California, Irvine School of Medicine, Orange, CA
4University of California - Davis, Sacramento, CA
5UCSF Benioff Children’s Hospital Oakland, Oakland, CA
6Endocrine and Diabetes Center, Miller Children's Hospital Long Beach, Long Beach, CA
7Pediatric Endocrinology, David Geffen School of Medicine at UCLA, Los Angeles, CA
8UCSF Benioff Children's Hospital, San Francisco, CA
9Rady Children's Hospital, San Diego, CA

Paul J. Hampel, MD1, Ying Huang, MS, MA2, Sarah Miller, BS3*, John N. Allan, MD4, Seema A Bhat, MD5, David A. Bond, MD, BS5, Danielle M. Brander, MD6, John C. Byrd, MD7, Julio C. Chavez, MD8, Elise A. Chong, MD9, Alexey Danilov, MD, PhD10, Matthew S. Davids, MD, MMSc11, Kaitlyn M. Dvorak-Kornaus, PhD5*, Hannah Freedman, RN12*, Nikita Malakhov, MD13, Matthew Matasar, MD, MS14, Cecelia Miller, PhD15, Sameer A. Parikh, MBBS16, Erin M. Parry, MD, PhD17, Kari G. Rabe, MS18*, Phil Raess, MD, PhD19*, Manoj Rai, MD20*, Joanna M. Rhodes, MD21, Kerry A. Rogers, MD5, Aditi Saha, MBBS22, Jake Schade, BA23*, Geoffrey Shouse, PhD, DO24, Stephen E Spurgeon, MD25, Deborah M. Stephens, DO26, Yucai Wang, MD, PhD16, Jennifer A. Woyach, MD27, Max Yano, MD, PhD28*, Omer Zulfa29* and Adam S Kittai, MD30

1Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
2Division of Hematology, Department of Statistics, The Ohio State University Wexner Medical Center, Columbus, OH
3Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus, OH
4Division of Hematology and Oncology, Weill Cornell Medicine, Long Island City, NY
5Division of Hematology, The Ohio State University, Columbus, OH
6Duke University, Durham, NC
7Department of Internal Medicine, University of Cincinnati, Cincinnati, OH
8Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
9Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
10City of Hope Comprehensive Cancer Center, La Canada Flintridge, CA
11Department of Medical Oncology, Dana-Farber Cancer Institute, Inc., Boston, MA
12Department of Medical Oncology, Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA
13Division of Hematology and Oncology, Weill Cornell Medicine, New York, NY
14Division of Blood Disorders, Rutgers Cancer Institute of New Jersey and RWJBarnabas Health, New York, NY
15Division of Pathology, The Ohio State University, Columbus, OH
16Division of Hematology, Mayo Clinic, Rochester, MN
17Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
18Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
19Department of Pathology and Laboratory Medicine, Oregon Health & Science University, Portland, OR
20Center for Hematologic Malignancies, Knight Cancer Institute, Oregon Health and Science University, Portland, OR
21Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
22Department of Hematology/Oncology, Moffitt Cancer Center, West Orange, NJ
23Rutgers Cancer Institute, New Brunswick, NJ
24City of Hope Cancer Center, Duarte, CA
25Knight Cancer Institute, Oregon Health & Science University, Portland, OR
26University of North Carolina Chapel Hill, Chapel Hill, NC
27Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH
28College of Medicine, The Ohio State University, Columbus, OH
29University of Cinncinati, Cincinatti, OH
30Icahn School of Medicine at Mount Sinai, New York, NY

Inna Y Gong, MD, PhD1, Bahar Rafinejad-Farahani, MPH2*, Haris Majeed2*, Mark Soto, MSc3*, Rena M Conti, PhD4*, Joseph M Unger, PhD5*, Carmen E Guerra, MD6*, Meredith Rosenthal, PhD7* and Danielle Rodin, MD, MPH8*

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Global Cancer Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
3Department of Health Policy and Management, Harvard T. H. Chan School of Public Health,, Boston, MA
4Department of Markets, Public Policy, and Law, Boston University Questrom School of Business, Boston, MA
5Fred Hutchinson Cancer Research Center, Seattle
6Division of General Medicine, Department of Medicine,Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
7Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA
8Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

Paul A. Hamlin, MD1, Pallawi Torka, MD1, Eric Hansen, MS2*, Andrew J. Belli, MPH2*, Jacob Ambrose, MS2*, Christina M. Zettler, MPH2*, Laura L. Fernandes, PhD2, Stephanie Wiley, RN, OCN2*, Brittney Perry, RN, OCN2* and Ching-Kun Wang, MD2*

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2COTA, Inc., New York, NY

Heidi Cho, MD1, Kausik Maiti, MD2*, Nancy Lunney, MA3*, Vladimir Otasevic, MD4* and Chris Learn, PhD3*

1Parexel, Denver, CO
2Parexel, , Durham, NC
3Parexel, Durham, NC
4Clinic for Hematology, University Clinical Center of Serbia, Belgrade, Serbia

Moazzam Shahzad, MD1, Eeman Ahmad2*, Shahzaib Ahmed2*, Umar Akram3*, Shoaib Ahmad4*, Muhammad Kashif Amin, MD5*, Fatima Tuz Zahra, MBBS6, Muhammad Umair Mushtaq5,7 and Michael V. Jaglal, MD8

1Department of Oncological Sciences, H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
2Fatima Memorial Hospital College of Medicine and Dentistry, Lahore, Pakistan
3Allama Iqbal Medical College, Lahore, Pakistan
4Punjab Medical College, Faisalabad, Pakistan
5Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
6H. Lee Moffitt Cancer Center, University of South Florida, Tampa, FL
7Mikael Rayaan Foundation Global Health Consortium, Kansas City, KS
8Department of Hematology/Oncology, Moffitt Cancer Center, Tampa, FL

Mahek Garg, PhD1, Ambika Satija, PhD2*, Yan Song, PhD2*, Ben Meade, BA3*, James Signorovitch, PhD2* and Shravanthi Gandra, PhD, MBA4*

1Merck Sharp & Dohme LLC, Rahway, NJ
2Analysis Group, Inc., Boston, MA
3Analysis Group, Inc, Paris, France
4Merck & Co., Inc., Rahway, NJ

Brittaney-Belle Elizabeth Gordon, MD1,2, Svea K. Wahlstrom, VMD, MS3*, Anna Teschemaker, PhD1*, Rachel H. Mackey, PhD, MPH4*, Diana DeVincenzo, PharmD3*, Leslie A. Carabuena, MSIE4*, Samantha L. Thompson, PhD5*, Ning A. Rosenthal, MD, PhD4* and Javid J. Moslehi, MD6*

1AstraZeneca, Gaithersburg, MD
2University of Pittsburgh Medical Center (UPMC), Hillman Comprehensive Cancer Center, Pittsburgh, PA
3AstraZeneca, Wilmington, DE
4Premier Inc, PINC AI Applied Sciences, Charlotte, NC
5AstraZeneca, Cambridge, United Kingdom
6Section of Cardi-Oncology & Immunology, University of California San Francisco, San Francisco, CA

Arshi Syal, MD1,2, Yajur Arya, MD1,2, Karecia Byfield, MBBS1,2*, Bruce Adrian Casipit, MD1,2*, Claudia Dourado, MD1,2 and Gabor Varadi, MD1,2*

1Albert Einstein Medical Center, Philadelphia, PA
2Thomas Jefferson University Hospital, Philadelphia, PA

Ayse Levent, MSc1*, Angelena Moseley2*, Rebecca Simons3* and Serafina Adabra4*

1Ipsos, New York, NY
2Ipsos Insight, LLC, Ambler, PA
3Ipsos Insight, LLC, Boston, MA
4Ipsos Insight, LLC, London, United Kingdom

Yo Saito, MD1*, Tetsuro Oda, MSc2*, Shimpei Nakanishi, BA2*, Minoru Ota, BA2*, Naoki Maeda, MSc2*, Daisuke Kozuka, MSc2* and Noriko Fukuhara, MD, PhD3

1Department of Hematology, Miyagi Cancer Center, Natori, Japan
2Drug Safety Division, Chugai Pharmaceutical Co., Ltd., Chuo-Ku, Japan
3Department of Hematology, Tohoku University School of Medicine, Sendai, Japan

Javid J. Moslehi, MD1*, Svea K. Wahlstrom, VMD, MS2*, Anna Teschemaker, PhD3*, Rachel H. Mackey, PhD, MPH4*, Diana DeVincenzo, PharmD2*, Leslie A. Carabuena, MSIE4*, Samantha L. Thompson, PhD5*, Brittaney-Belle Elizabeth Gordon, MD3,6 and Ning A. Rosenthal, MD, PhD4*

1Section of Cardi-Oncology & Immunology, University of California San Francisco, San Francisco, CA
2AstraZeneca, Wilmington, DE
3AstraZeneca, Gaithersburg, MD
4Premier Inc, PINC AI Applied Sciences, Charlotte, NC
5AstraZeneca, Cambridge, United Kingdom
6University of Pittsburgh Medical Center (UPMC), Hillman Comprehensive Cancer Center, Pittsburgh, PA

Jason M Stevenson, MD1,2*, Anjali Khanna, MBBS, MPH1,2*, Ashleigh Hawk, MPH1,2*, Avery Morse1,2*, Oyin Alao, MPH1,2*, Katherine Jordan1,2*, Xu Ji, PhD1,2,3, Heeju Sohn, PhD4*, Sharon M. Castellino, MD, MSc1,2 and Tamara P. Miller, MD, MSCE1,2

1Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
2Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplant, Emory University School of Medicine, Atlanta, GA
3Department of Health Policy and Management, Emory University Rollins School of Public Health, Atlanta, GA
4Department of Sociology, Emory University, Atlanta, GA

Francesco Iadevaia, MD1*, Ramsay Hafer, BS2*, Thomas Z Rohan, BS3*, Alan Khoo, MBBS3,4*, Luca Laurenti, MD5* and Pierluigi Porcu, MD4,6

1Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica Del Sacro Cuore, Roma, Italy
2Department of Dermatology and Cutaneous Biology, Thomas Jefferson University, Philadelphia, PA
3Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA
4Department of Medical Oncology, Thomas Jefferson University, Philadelphia, PA
5Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Universitaria Policlinico Agostino Gemelli, Rome, Italy
6Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA

Hazim Ababneh, MD1, Andrea Ng, MD, MPH2*, Andrzej Niemierko, PhD1*, Matthew Frigault, MD, MS3, Caron A. Jacobson, MD, MMSc4 and Chirayu Patel, MD, MPH1*

1Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA
2Radiation Oncology, Dana-Farber Cancer Institute, Boston, MA
3Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA
4Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Inna Y Gong, MD, PhD1, Meredith Rosenthal, PhD2*, Mark Soto, MSc3*, Bahar Rafinejad-Farahani, MPH4*, Joseph M Unger, PhD5*, Carmen E Guerra, MD6*, Rena M Conti, PhD7* and Danielle Rodin, MD, MPH8*

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Department of Health Policy and Management, Harvard T. H. Chan School of Public Health, Boston, MA
3Department of Health Policy and Management, Harvard T. H. Chan School of Public Health,, Boston, MA
4Global Cancer Program, Princess Margaret Cancer Centre, Toronto, ON, Canada
5Fred Hutchinson Cancer Research Center, Seattle
6Division of General Medicine, Department of Medicine,Hospital of the University of Pennsylvania, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
7Department of Markets, Public Policy, and Law, Boston University Questrom School of Business, Boston, MA
8Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

Joanna M. Rhodes, MD, MSCE1*, Naleen Raj Bhandari, Ph.D2*, Manoj Khanal, Ph.D2*, Dan He, M.Sc3*, Sarang Abhyankar, MD, Ph.D2, John M. Pagel, MD, Ph.D, DSc2, Lisa M. Hess, Ph.D2* and Alan P Skarbnik, MD4

1Rutgers Cancer Institute of New Jersey, New Brunswick, NJ
2Eli Lilly and Company, Indianapolis, IN
3Syneos Health, Morrisville, NC
4Novant Health Cancer Institute, Charlotte, NC

Zixun Yan1*, Dehui Zou2*, Wenbin Qian3*, Ying Lu4*, Yuhua Li5*, Dongmei Ji6*, Xiaojian Zhu7*, Heng Mei, md, phd8*, Ping Li9*, Changju Qu, MD, PhD10*, Lei Zhang11*, Keshu Zhou12*, Hongmei Jing13*, Ting Niu, MD, PhD14, Chunyan Ji15, Lanfang Li16*, Hua Yang17*, Fei Li18, Wei Wang19*, Kailin Xu20*, Jinghua Zhao21*, Depei Wu, MD, PhD22, Yu Hu8* and Weili Zhao1

1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China
2State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
3Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
4Department of Hematology, The Affiliated People's Hospital of Ningbo University, Ningbo, China
5Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
6Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China
7Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
9Department of Hematology, Tongji Hospital, Tongji University School of Medicine, Shanghai, China
10The First Affiliated Hospital of Soochow University, National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, Suzhou, China
11Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
12Department of Hematology, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China
13Department of Hematology and Lymphoma Research Center, Peking University Third Hospital, Beijing, China
14Department of Hematology, West China Hospital, Sichuan University, Chengdu, China
15Department of Hematology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China
16Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin’s Clinical Research Center for Cancer, the Sino-US Center for Lymphoma, Tianjin, China
17Department of Hematology, Hongkong University-Shenzhen Hospital, Shenzhen, China
18Center of Hematology, The First Affiliated Hospital of Nanchang University, Nanchang, China
19Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China
20Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
21Department of Clinical Development & Medical, Fosun Kite Biotechnology Co. Ltd., Shanghai, China
22Department of Hematology, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases, Suzhou, China

Mengyang Di, MD, PhD1, Carrie I Ho, MD2, Stephen D. Smith, MD2, Mazyar Shadman, MD, MPH2,3, Chaitra S. Ujjani, MD2, Ryan C. Lynch, MD4, Christina Poh, MD2, Vikram Raghunathan, MD2*, Brian G. Till, MD2,4, Edus H. Warren, MD, PhD2,5, Ajay K. Gopal, MD1 and Stephanie J. Lee, MD, MPH3

1University of Washington, Seattle, WA
2Division of Hematology and Oncology, University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
4Fred Hutchinson Cancer Center, University of Washington, Seattle, WA
5Fred Hutchinson Cancer Center, Seattle, WA

Tammarah Sklarz, MD1, Tesla DuBois, MS2,3* and Shannon Lynch, PhD2,4*

1Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA
2Fox Chase Cancer Center Division of Cancer Prevention and Control, Philadelphia, PA
3Temple University Geography and Urban Studies, Philadelphia, PA
4Temple University School of Medicine Center for Biostatistics and Epidemiology, Philadelphia, PA

Jia Yi Tan, MD1, Yong Hao Yeo, MBBS2*, Qi Xuan Ang, MBBS3*, George Chen, MD4 and Kok Hoe Chan, MD5

1Department of Internal Medicine, Saint Michael's Medical Center, Newark, NJ
2Department of Internal Medicine/Pediatrics, Corewell Health, Royal Oak, MI
3Department of Internal Medicine, Sparrow Health System and Michigan State University, East Lansing, MI
4Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
5Charleston Area Medical Center, Charleston, WV

John L Vaughn, MD, MS1 and Narendranath Epperla, MD, MS2

1NYU Grossman Long Island School of Medicine, Mineola, NY
2Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Gilad Itchaki, MD1,2*, Talish Razi, MPH3*, Adi Zoref-Lorenz, MD4, Martin H. Ellis, MD1,2* and Ronen Arbel, PhD3,5*

1Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
2Hematology Institute, Meir Medical Center, Kfar Saba, Israel
3Community Medical Services Division, Clalit Health Services, Tel Aviv, Israel
4Hematology Institute, Meir Medical Center, Faculty of Medicine, Tel Aviv University, KFAR-SABA, Israel
5Maximizing Health Outcomes Research Lab, Sapir College, Sderot, Israel

Kunhwa Kim, MD1, Amy Ayers, MPH2*, Sairah Ahmed, MD2, Linda Claret2*, Paolo Strati, MD2, Ranjit Nair, MD2*, Chijioke Nze, MD, MPH2, Jeremy Ramdial, MD3, Janet Torres3*, Elizabeth J. Shpall, MD3, Luis E. Fayad, MD4, Loretta Nastoupil2*, Jason R. Westin, MD2, Christopher R. Flowers, MD, MS2, Sattva S. Neelapu, MD2 and Dai Chihara, MD, PhD2

1Division of Cancer Medicine, The University of Texas MD Anderson, Houston, TX
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
4The University of Texas MD Anderson Cancer Center, Houston, TX

Abraham Mullasseril Varghese, MBBS, MRCP , PhD1,2, Lauren Wright, MSc3*, Talha Munir, MBBS, PhD4, Russell Patmore, FRCPath5, Catherine Parbutt6* and Alexandra Smith, PhD7*

1Department of Haematology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
2Department of Haematology, St James's University Hospital, Leeds, United Kingdom
3University of York, York, United Kingdom
4Department of Haematology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
5Hull University Teaching Hospitals NHS trust, Driffield, ENG, GBR
6Leeds teaching hospitals NHS trust, Leeds, GBR
7Epidemiology and Cancer Statistics Group, Department of Health Sciences, University of York, York, United Kingdom

Michael Schneider, MD, PhD1, Elise A. Chong, MD1, Stefan K. Barta, MD1, Sunita D. Nasta, MD1, Jakub Svoboda, MD1, Jordan Carter, MD1*, Michael Roderick Cook, MD1, Nasheed Hossain, MD1*, Stephen J. Schuster, MD1, Heather Difilippo, CRNP1*, John P Plastaras, MD, PhD1*, Michael Lariviere, MD1*, Marco Ruella, MD2, David L. Porter, MD1, Noelle Frey, MD, MS3 and Daniel J. Landsburg, MD1

1School of Medicine, Division of Hematology/Oncology, University of Pennsylvania, Philadelphia, PA
2Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
3University of Pennsylvania, Philadelphia, PA

Shlomzion Aumann1*, Abraham Avigdor, MD2, Ronit Marcus, MD2*, Netanel A. Horowitz, MD3,4*, Ronit Gurion5*, Tamar Tadmor, MD6*, Roy Vitkon, MD7*, May Meira Basood, MD8*, Uri Abadi, MD9* and Meirav Kedmi, MD2*

1Department of Hematology, Hadassah Medical Center and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel
2Division of Hematology & Bone marrow transplantation, Chaim Sheba Medical Center, Tel-Hashomer, Israel, School of Medicine, Tel-Aviv University, Tel Aviv, Israel
3Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel
4Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel
5Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center & Faculty of Medicine and Health Sciences, Tel-Aviv University, Tel Aviv, Israel
6Hematology Unit, Bnai Zion Medical Center, Haifa, Israel
7Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
8Assuta hospital, Tel Aviv, Israel
9Hematology Institute, Meir Medical Center, Kfar Saba, Israel

Matthew Newman, MD1, Zimin Zhuang, MS2*, Chun R. Chao, PhD, MS3* and Robert Cooper, MD4*

1Department of Internal Medicine, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA
2Department of Research & Evaluation, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA
3Department of Research & Evaluation, Kaiser Permanente Southern California, Pasadena, CA
4Department of Pediatric Hematology/Oncology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA

Serif Sungur, BMedSci (Hons)1*, Yao Yao, MBBS2*, Cameron Wellard, BSc (Hons), PhD3*, Eliza Chung, BSc, MPH4*, Susan Morgan, MBBS, FRACP, FRCPA5*, Denise Lee, MBBS, FRACP, FRCPA6*, Geoffrey Chong7,8, Chan Y. Cheah, MBBS DMSc9, Tasneem Rizvi10*, Eliza A. Hawkes, MD11,12, Zoe K McQuilten, MBBS, PhD13, Erica M. Wood, MD14, Nada Hamad, MBBS, MSc, BSc15,16,17, Tasman Armytage, MBBS, BSc, FRACP, FRCPA2* and Anna M. Johnston, FRACP, MBBS, FRCPA18,19

1School of Medicine, University of Tasmania, Launceston, TAS, Australia
2Gosford Hospital, Gosford, Australia
3School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia
4Monash University, Melbourne, AUS
5Alfred Health, Melbourne, VIC, Australia
6Austin Hopsital, Melbourne, Australia
7Olivia Newton-John Cancer Wellness & Research Centre, Austin Hospital, Heidelberg, VIC, Australia
8Ballarat Regional Integrated Cancer Centre, Ballarat Central, VIC, Australia
9Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
10Department of Haematology, Royal Hobart Hospital, Hobart, Australia
11School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
12Austin Health, Olivia Newton John Cancer Research Institute, Heidelberg, VIC, Australia
13Transfusion Research Unit, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
14Monash University, Melbourne, Australia
15St Vincent's Hospital, Sydney, NSW, Australia
16School of Clinical Medicine, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
17School of Medicine, University of Notre Dame, Sydney, Australia
18Royal Hobart Hospital, Hobart, Australia
19University of Tasmania, Hobart, Australia

Rishab Prakash, BS1*, James Long, PhD2*, Benjamin Mescher3*, Paul Edelkamp Jr.4*, Mark Knafl, MS5*, Jeff Jin6*, Trey Kell7*, Naveen Garg, MD8*, Ajlan Al Zaki, MD, PhD9, Dai Chihara, MD, PhD1, Luis Malpica, MD1*, Ranjit Nair, MD1* and Swaminathan P Iyer, MD1*

1Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston, TX
4Department of Enterprise Data Engineering & Analytics, The University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
6M.D. Anderson Cancer Center, Houston, TX
7MD Anderson Cancer Center, Texas, TX
8Department of Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma/Myeloma and Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX

Karan Gowda, MPH1,2*, Medha Gupta2,3*, Adrian Aguliar2,4*, Carlos Cruz2,5*, Elizabeth Rodriguez6, Sairah Ahmed, MD7, Branko Cuglievan, MD8, Efstratios Koutroumpakis, MD9*, Michael E. Roth, MD8 and Michelle A.T. Hildebrandt, PhD10

1Chicago Medical School, North Chicago
2University of Texas MD Anderson Cancer Center, Houston
3Drexel University College of Medicine, Philadelphia
4Macalester College, St. Paul
5Rice University, Houston
6The University of Texas MD Anderson Cancer Center, Houston
7Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
8Division of Pediatrics, MD Anderson Cancer Center, Houston, TX
9University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Vinod Kumar, MBBS1*, Shaykhah Alotaibi, MD2*, Zhuo Li, MS3*, Ernesto Ayala, MD1, Mohamed A. Kharfan-Dabaja, MD, MBA1 and Madiha Iqbal, MD4

1Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
2Dept of Hematology, Stem Cell Transplantation and Cellular Therapy , KFSHRC, Riyadh, Saudi Arabia
3Division of Biomedical Statistics and Informatics, Mayo Clinic, Jacksonville
4Division of Hematology and Medical Oncology, Mayo Clinic, Jacksonville, FL

Rahela Aziz-Bose, MD1,2,3,4, Lucille Lokko, BA4*, Morgan A. Paul, MS5*, Colleen A. Kelly, MD3,4, Leanne Duhaney, MD, MPH6*, Puja J. Umaretiya, MD7*, Fang Fang Zhang, MD, PhD8*, Lisa B. Kenney, MD2,3,4* and Kira Bona, MD, MPH2,3,4,9

1Division of Population Sciences, Dana-Farber Cancer Institute, Jamaica Plain, MA
2Department of Pediatrics, Harvard Medical School, Boston, MA
3Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA
4Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
5Department of Data Science, Dana-Farber Cancer Institute, Boston, MA
6Department of Cardiology, Boston Children's Hospital, Boston, MA
7Division of Pediatric Hematology/Oncology, University of Texas Southwestern Medical Center, Dallas, TX
8Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA
9Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA

Shubham Adroja, MBBS1, Ethan A Burns, MD1, Noah Giese, MD, MEng2*, Sunil Mathur1*, Meera Khosla, MD2*, Jacqueline Rios2*, Hala S Hassanain, MD3*, Premal D. Lulla, MBBS4, Carlos A. Ramos, MD2,5, Carrie Yuen, MD1*, Chih-Hang Anthony Tang, MD, PhD6, Chih-Chi Andrew Hu, PhD7, Siddhartha Ganguly, MD2, Helen Elisabeth Heslop8 and Sai Ravi Kiran Pingali, MD1

1Houston Methodist Neal Cancer Center, Houston Methodist Hospital, Houston, TX
2Houston Methodist Hospital, Houston, TX
3Internal Medicine, Department of Academic Medicine, Houston, TX
4Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital, Texas Children's Hospital, Houston, TX
5Center for Cell and Gene Therapy, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital, Houston, TX
6Houston Methodist Research Institute, Houston Methodist Hospital, Houston, TX
7Houston Methodist Research Institute, Houston, TX
8Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX

Gareth P. Gregory, MBBS(Hons), PhD, FRACP, FRCPA1, Jeremy S. Abramson, MD2, Hui-Qiang Huang3*, Qing-Yuan Zhang4*, Matthew Ku, MBBS, PhD5*, Dok Hyun Yoon, MD, PhD6, Christopher P. Fox, MBChB(Hons), PhD, FRCP7, Haifaa Abdulhaq8, William Townsend9*, Joan Ashby10*, Alana Harris11*, Victor Orellana-Noia10*, Stephen Simko10*, Martine Kallemeijn12*, Richard Ta10*, James Relf11*, Huang Huang, MSc13*, Linda Lundberg12* and Huilai Zhang, MD14

1School of Clinical Sciences at Monash Health, Monash University, Melbourne, Australia
2Massachusetts General Hospital Cancer Center, Boston, MA
3Sun Yat-Sen University Cancer Center, Guangzhou, China
4Harbin Medical University Cancer Hospital, Harbin, China
5St Vincent's Hospital, University of Melbourne, Melbourne, Australia
6Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea, Republic of (South)
7School of Medicine, University of Nottingham, Nottingham, United Kingdom
8University of California San Francisco, Fresno Campus, California, CA
9University College London Hospitals, London, United Kingdom
10Genentech, Inc., South San Francisco, CA
11Roche Products Ltd, Welwyn Garden City, United Kingdom
12F. Hoffmann-La Roche Ltd, Basel, Switzerland
13Hoffmann-La Roche Ltd, Mississauga, ON, Canada
14Tianjin Medical University Cancer Institute, Tianjin, China

Vincenzo J Pizzuti, MD, MSc1*, Kaitlyn Hoover, MS2*, Jamie L Studts, PhD3*, Tyler W. Buckner, MD, MSc4, Benjamin Brewer, PsyD1* and Ajay Major, MD, MBA1

1Division of Hematology, University of Colorado School of Medicine, Aurora, CO
2University of Colorado Cancer Center, University of Colorado School of Medicine, Aurora, CO
3Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO
4Hemophilia and Thrombosis Center, University of Colorado School of Medicine, Aurora, CO

Tiana Kordbacheh, MBBS, PhD, BSc1, Anca Prica, MD, MSc1,2*, Kelvin KW Chan, MD, PhD3*, Mahmood Aminilari, PhD4*, Zharmaine Ante5*, Ning Liu, PhD6*, Inna Y Gong, MD, PhD1,2, Sita Bhella, MD1,2*, Michael Crump, MD1,2*, Abi Vijenthira, MD, SM2,7, John Kuruvilla, MD, FRCPC2,8, Robert Kridel, MD, PhD1,2, Christine I Chen, MHPE, MD2,9, Vishal Kukreti, MD, MSc2,7, Chloe Yang, MD2,10*, Nauman Malik4,11*, David Hodgson, MD4,11* and Danielle Rodin, MD, MPH4,11*

1Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Department of Medicine, University of Toronto, Toronto, ON, Canada
3Division of Hematology and Oncology, Department of Medicine, University of Toronto, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada
4Department of Radiation Oncology, University of Toronto, Toronto, ON, Canada
5Research & Analysis, ICES, Toronto, ON, Canada
6ICES, Toronto, ON, Canada
7Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
8Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
9Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
10Princess Margaret Cancer Centre, Toronto, ON, Canada
11Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, ON, Canada

John Sharp, MD1, Rina Li Welkie, MPH2, Lexus Frazier, PharmD, BCOP3*, Timothy Voorhees, MD, MSc4, Polina Shindiapina, MD, PhD4*, Robert Baiocchi, MD, PhD1 and Ashley Rosko, MD5

1James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
2The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH
3Department of Pharmacy, The James Cancer Hospital and Solove Research Institute at The Ohio State University, Columbus, OH
4Division of Hematology, The Ohio State University, Columbus, OH
5The Ohio State University, Columbus, OH

Elisabet Viayna, PhD1*, Miriam Haviland2*, Jiani Zhou3*, Michelle McCrory4*, Edward CaJacob3*, Kim Hanna3*, James Jordan, PharmD5* and Elisabeth Calderón-Gómez6*

1Grifols, Sant Cugat Del Vallès, AL, Spain
2IQVIA, Durham, NC
3Grifols, Durham
4Grifols, Dublin, Ireland
5Grifols, Research Triangle Park, NC
6Grifols, Sant Cugat del Valles, Spain

Chun-Kai Liao, MD1*, Chia-Jen Liu, MD, PhD2,3,4, Tran-Der Tan5, Ming-Chung Wang6*, Ya-Ting Hsu7*, Hung-Lin Liu8*, Shang-Ju Wu9*, Hsueh-Ju Lu10*, Jeng-Shiun Du, MD11*, Wan-Jhen Gao, MD12* and Cheng-Chih Tsai13*

1Hematology-oncology, E-DA Dachang Hospital, I-Shou University,, Kaohsiung, Taiwan
2Taipei Veterans General Hospital, Taipei, Taipei (City), TWN
3Taipei Veterans General Hospital, Taipei, Taipei (city), TWN
4Taipei Veterans General Hospital, Taipei, TWN
5Koo Foundation Sun Yat Sen Cancer Center, Taipei City, Taiwan
6Chang Gung Memorial Hospital, Kaohsiung, Taiwan
7National Cheng Kung University Hospital, Taiwan, R.O.C., TWN
8Kaohsiung-Chang Gang Memorial Hospital, Kaohsiung, TWN
9Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan
10Division of Hematology and Oncology, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan
11Division of Hematology/Oncology, department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
12Division of Hematology-Oncology, Chi Mei Medical Center, Tainan, TWN
13Division of Hematology and Oncology, Taitung MacKay Memorial Hospital, Taitung, Taiwan

*signifies non-member of ASH